Klotho Neurosciences (NASDAQ:KLTO) Announces Earnings Results

Klotho Neurosciences (NASDAQ:KLTO) issued its earnings results on Monday. The company reported ($0.07) EPS for the quarter, Zacks reports.

Klotho Neurosciences Price Performance

KLTO traded up $0.00 during trading on Monday, reaching $0.23. 55,642 shares of the company were exchanged, compared to its average volume of 739,279. Klotho Neurosciences has a 52 week low of $0.21 and a 52 week high of $13.10. The business’s 50 day moving average price is $0.34.

About Klotho Neurosciences

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.